INSUBCONTINENT EXCLUSIVE:
NEW DELHI: Decent gains in shares of Dr
Reddy's Laboratories (up 2.20 per cent) and Sun Pharmaceutical Industries (up 2.03 per cent) were keeping the pharma index in the green in
afternoon trade on Thursday
Sun Pharmaceutical advanced on Thursday as the pharma major got a go-ahead from the US Food and Drug Administration (USFDA) for its
The drugmaker on Tuesday reported a consolidated net profit of Rs 982.51 crore for the June quarter
It had registered a net loss of Rs 424.92 crore in the year-ago quarter
The Nifty Pharma index was trading 0.77 per cent up at 9,554 around 12:35 pm
Cipla (up 1.14 per cent), Biocon (up 1.04 per cent) and Lupin (up 0.31 per cent) were also in the green.
However, losses in Piramal
Enterprises (down 2.32 per cent), Cadila Healthcare (down 1.90 per cent), Glenmark Pharmaceuticals (down 0.54 per cent) and Aurobindo Pharma
(down 0.21 per cent) capped the gains for the index
Shares of Divi's Laboratories (up 0.08 per cent) were nearly flat
Equity market was dull amid weak global cues as a political crisis in Turkey and US-China trade war woes weighed on investor sentiment.
An
unabated fall of the Indian rupee and sustained capital outflow in the wake of a continuous rise of US dollar also hit the market
Benchmark NSE Nifty50 index was down 16 points at 11,419, while the BSE Sensex was 35 points down at 37,817
Among the 50 stocks in the Nifty index, 28 were trading in the green, while 22 were in the red.
GAIL (India), Dr
Reddy's Laboratories, Sun Pharma, Axis Bank and Grasim Industries were among the top gainers in the Nifty index.
Kotak Mahindra Bank,
Vedanta, Ultratech Cement, Hindalco Industries and Indiabulls Housing Finance were among the top losers in the Nifty pack of stocks.
